Adam Nouveau

Adam Nouveau is currently the Associate Director at Autolus Ltd., where Adam manages QC Operations for Cell & Gene Therapy. Prior to this role, Adam held positions such as Senior Manager and Team Leader in Quality Control at Cellforcure. Adam has a strong background in managing QC operations for CAR-T cell therapies, including Kymriah®, the first FDA-approved CAR-T cell therapy. Adam also has experience in immunological studies, vaccine research, and tissue engineering. Adam holds a Master of Science in Biotechnology and Management and has a Bachelor of Sciences in Biochemistry.